Skip to main navigation Skip to search Skip to main content

Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma

  • Lucas Moreno
  • , Ian F. Pollack
  • , Patricia K. Duffner
  • , J. Russell Geyer
  • , Jacques Grill
  • , Maura Massimino
  • , Jonathan L. Finlay
  • , Stergios Zacharoulis
  • Royal Marsden NHS Foundation Trust
  • University of Pittsburgh
  • Children's Hospital and Regional Medical Center Seattle
  • Institut Gustave Roussy
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • Children's Hospital Los Angeles

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

The role of cytology of cerebrospinal fluid (CSF) has not been established in pediatric ependymoma. Thirty-two children with metastatic ependymoma were analyzed: 11 patients had only positive CSF cytology, 6 had only positive magnetic resonance imaging (MRI) findings, and 15 had both CSF cytology and MRI positive. Twenty-two patients relapsed. Five-year event-free survival was 27.3% ± 13.4% for children with only CSF positive (Ml) versus 26.1% ± 10.2% for patients with positive spine MRI positive (with or without CSF positive, M3) (P = 0.87). In conclusion, 34% of the patients with metastatic ependymoma were identified based on CSF cytology only and their outcome was comparable to patients with macroscopic disease. CSF cytology is a useful tool to stage newly diagnosed patients with ependymoma.

Original languageEnglish
Pages (from-to)515-518
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume32
Issue number6
DOIs
StatePublished - Aug 2010

Keywords

  • CSF cytology
  • Metastatic ependymoma
  • Prognosis

Fingerprint

Dive into the research topics of 'Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma'. Together they form a unique fingerprint.

Cite this